Safety of rapid allergen vaccination in children utilizing a 2.5-hour protocol

Pediatric Asthma, Allergy and Immunology

Volumn 18, Issue 3, 2005, Pages 131-139

  Smits, William ^a,b   Giese, Jeannie ^a   Letz, Kevin ^a,c,d   Schlie, Austin ^a  

^a Allergy and Asthma Center   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PHOENIX   (United States)

^d INDIANA WESLEYAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CETIRIZINE; FEXOFENADINE; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; LEVALBUTEROL; LORATADINE; PIRBUTEROL ACETATE; PREDNISOLONE; PREDNISONE; RAGWEED ANTIGEN; SALBUTAMOL;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANAPHYLAXIS; ARTICLE; CAT; CHILD; COUGHING; DOSE TIME EFFECT RELATION; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SYSTEMIC DISEASE; VACCINATION;

EID: 24944509509     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2005.18.131     Document Type: Article

References (30)

1. Creticos PS. Immunotherapy with allergens. JAMA 1992; 268:2834-2839.
2. McHugh SM, Lavelle B, Kemeny DM, et al. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronysinus in allergic rhinitis, comparing clinical outcome with changes in antigen specific IgE, IgG, and IgG subclasses. J Allergy Clin Immunol 1990; 86:521-531.
3. Norman P, Van Metre TE. The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990; 85:522-525.
4. Ross R, Nelson H, Finefold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies. Clin Ther 2000; 22:342-350.
5. Bousquet J, Michel FB. Specific immunotherapy in asthma: is it effective? J Allergy Clin Immunol 1994; 94:1-11.
6. Cantani A, Businco E, Benincori N, et al. A three-year controlled study in children with pollinosis treated with immunotherapy. Ann Allergy 1984; 53:79-84.
7. Cantani A, Arcese G, Lucenti P, et al. A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. J Investig Allergol Clin Immunol 1997; 7:90-97.
8. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purifed extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993; 91:709-722.
9. Mailing HJ. Allergen-specific immune therapy in the treatment of asthma. Ugeskr Laeger 2000; 162:477-479.
10. Nagata M, Yamamoto H, Tabe K, et al. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: changes in in vivo and in vitro responses to HDM. Intern Med 1993; 32:702-709.
11. Ross R, Nelson H, Finefold I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther 2000; 22:329-341.
12. Bernstein DI, Mittman RJ, Kagen SL, et al. Clinical and immunologic studies of rapid venom immunotherapy in hymenoptera-sensitive patients. J Allergy Clin Immunol 1989; 84:951-959.
13. Ross R, Nelson H, Finefold I. Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: a meta-analysis. Clin Ther 2000; 22:351-358.
14. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993; 91:734-737.
15. Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993; 70:480-482.
16. Bousquet J, Calvayrac P, Guerin B, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985; 76:734-744.
17. Hejjaoui A, Ferrando R, Dhivert H, et al. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 1992; 89:925-933.
18. Bousquet J, Guerin B, Dotte A, et al. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy. Clin Allergy 1985; 15:179-192.
19. Sundin B, Lilja G, Graff-Lonnevig V, et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. J Allergy Clin Immunol 1986; 77:478-487.
20. Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol with patients suffering from asthma. J Allergy Clin Immunol 1989; 83:797-802.
21. Hejjaoui A, Dhivert H, Michel FB, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990; 85:473-479.
22. Portnoy J, King K, Kanarek H, et al. Incidence of systemic reactions during rush immunotherapy. Ann Allergy 1992; 68:493-498.
23. Stewart GE II, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 1992; 90:567-578.
24. Sharkey P, Portnoy J. Rush immunotherapy: experience with a one-day schedule. Ann Allergy Asthma Immunol 1996; 76:175-180.
25. Smits W, Inglefield JT, Letz K, et al. Improved immunotherapy with a rapid allergen vaccination schedule: a study of 137 patients. Ear Nose Throat J 2003; 82:881-887.
26. Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114:371-376.
27. Nielson L, Johnsen CR, Mosbech H, et al. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996; 97:1207-1213.
28. Portnoy J, Bagstad K, Kanarek H, et al. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy 1994; 73:409-418.
29. Allergen immunotherapy: therapeutic vaccines for allergic diseases. 1998; Allergy 44(Suppl):1-42.
30. Rudd S. Immunotherapy compliance-a shot in the dark. Ann Allergy Asthma Immunol 1995; 74:195-198.